July 2013 FDA Recall Drug by Procter & Gamble Co
D-827-2013 - Unit Dose Mispackaging

This Class II drug recall was voluntarily initiated by Procter & Gamble Co on July 3, 2013 for the product Drug. The FDA reported the reason for recall as unit dose mispackaging. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-827-2013

Reason for Recall
Unit Dose Mispackaging: Product packaging defect which could result in code date smearing, incomplete blister card cuts, and missing or incorrectly placed liquicaps within the blisters.
Initiated
07-03-2013
Reported
08-07-2013
Quantity
35,568 cartons

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
DayQuil Sinex DayTime Sinus Relief (acetaminophen 325 mg and phenylephrine HCl 5 mg) liquicaps and NyQuil Sinex NightTime Sinus Relief (acetaminophen 325 mg, doxylamine succinate 6.25 mg, and phenylephrine HCl 5 mg) liquicaps Combopack, each 48-count liquicaps per carton contains 32 DayQuil Sinex DayTime Liquicaps and 16 NyQuil Sinex NightTime Liquicaps per carton, Made In Canada, Dist. by Procter & Gamble, Cincinnati, OH 45202, UPC 3 23900 01454 1.

Batch or Lot Expiration Information

Lot# 3051171961, Exp 09/14; Brand Code 84855363